Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

384 Ibodutant
149dcf386d240a6d0636ae8fa96d2d8d48f5c159d4c10a30465ffbda6bf93a37

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Ibodutant was a candidate drug for irritable bowel syndrome diarrhea, developed by The Menarini Group. , it underwent a multicentre double blind efficacy clinical study. Ibodutant selectively blocks the tachykinin receptor NK2, with blockade practically complete in nanomolar concentrations. A phase 2 trial in Europe (the IRIS-2 trial) completed in May 2012 with positive results. A 52-week phase 3 study was terminated as of 2015 because of low response and negative results of study NAK-06.

From Wikipedia, the free encyclopedia. License: CC BY-SA.